Models incorporating micronecrosis displayed better predictive accuracy in predicting 5-year RFS in patients with HCC after liver transplantation than models based on the Milan criteria, MELD score, and AFP level alone. The gene discussed is AFP; the disease is hepatocellular carcinoma.